Back to top

CVS Maintains Outperform Rating -- Price Target Lowered to $125

CVS Maintains Outperform Rating -- Price Target Lowered to $125

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

CVS Health Corporation (CVS)